The presence of pre-S polypeptides in paraffin wax embedded liver sections from the biopsy specimens of 15 hepatitis B surface antigen (HBsAg) seropositive patients (five with chronic persistent hepatitis (CPH), four with chronic active hepatitis (CAH), four with cirrhosis and two "healthy" HBsAg carriers) was investigated using monoclonal antibodies directed to distinct epitopes on pre-Sl (18/7 and TO 606) and pre-S2 (5535 and Q 19/10). Pre 
Hepatitis B virion consists of an envelope and a nucleocapsid. The envelope contains the polypeptides P 39/GP 42 (large), GP 33/GP 36 (middle), and P 24/GP 27 (major), encoded, respectively, by pre-Sl/pre-S2/S, pre-S2/S, and S-subregions of the viral genome.lA The role of pre-S polypeptides in the natural history of the hepatitis B virus (HBV) infection has not yet been fully elucidated, though recent evidence implicates pre-Sl,5 and less convincingly, pre-S2,67 in the binding of virions to a putative receptor on the surface of hepatocytes. The distribution of pre-S polypeptides in the liver tissue and its relation to disease severity and HBV replicative activity is a focus of current research. 8 The intrahepatocytic accumulation of HBV encoded products, especially the surface antigen,"' has long been related to a "ground glass" appearance of whole or portion of hepatocyte cytoplasm, seen on haematoxylin and eosin stained liver sections, and more clearly shown by either orcein, aldehydefuchsin, or Victoria blue staining.
Using a panel of monoclonal antibodies to well defined pre-S epitopes we investigated the presence and distribution of pre-S polypeptides in paraffin wax embedded, "ground glass" positive, liver biopsy specimens from patients with a variety of HBV related liver diseases and diverse HBV replication activity.
The histological material comprised 15 consecutive formalin fixed "ground glass" positive liver biopsy specimens from 15 hepatitis B surface antigen (HBsAg) seropositive patients. This selection criterion ensured the presence of cells containing envelope proteins in all the specimens. Eleven patients were men and four women, the age ranging between 17-54 years (mean age 37 8). The histological diagnosis, made according to internationally agreed criteria,'4 was of chronic persistent hepatitis in five, chronic active hepatitis in four, cirrhosis in four and minimal changes ("healthy HBsAg carriers) in two. Seven patients were HBe antigen positive, while eight were HBe antibody positive. Eight patients carried hepatitis core antigen (HBcAg) in their livers as detected by an indirect immunofluorescence technique,'5 while core antigen was absent from the livers of the remaining seven patients (table 1) .
MONOCLONAL ANTIBODIES TO PRE-S DETERMINANTS
We studied pre-SI using monoclonal antibodies TO 606 and MA 18/7 and pre-S2 using monoclonal antibodies 5535 and Q 19/ 10. TO 606 and 5535 were donated by Sorin Biomedica, Saluggia, Italy; MA 18/7 and Q 19/10 were a gift of Professor Wolfram Gerlich, Gottingen, Germany. The fine specificity of these monoclonal antibodies has previously been described'6 and was further confirmed in our laboratory by the use of solid phase enzyme linked immunosorbent assay (ELISA) with synthetic pre-Sl and pre-S2 peptides. MA 18/7 reacted with the 12-47 pre-Si peptide while TO 606 reacted with the C-terminus (peptide 95-117) of pre-S 1. Neither of these monoclonal antibodies recognised pre-S2 determinants. Conversely, Q 19/10 and 5535 did not react with pre-SI peptides but recognised the 120-145 pre-S2 peptide. Table 2 describes the Ig subclass and specificity of the monoclonal antibodies used, as ascertained in an ELISA, in which pre-S peptides were used in solid phase coated on to wells of a microtitre plate. HBsAg was detected using fluorescein isothiocyanate (FITC) conjugated rabbit anti-HBsAg antiserum (Behring, Marburg, Germany).
IMMUNOHISTOCHEMICAL STAINING
In preliminary experiments we selected a 7 2). The sections were initially stained in immunofluorescence, using monoclonal antibodies in the first step and FITC conjugated rabbit anti-mouse immunoglobulin antiserum (Dako, Denmark), diluted 1 in 20, in the second step. Because three sections were mounted on each slide, the staining produced by the reference anti- The results of both immunofluorescence and immunoperoxidase staining were recorded on a "0", " +", to " + + + " scale, according to staining intensity. Additional staining experiments were performed on pronase (Sigma) digested sections (0 05% pronase for 60 minutes at 37'C). The peroxidase staining pattern was compared with that produced by conventional histological methods (haematoxylin and eosin and orcein).
Results
The results obtained by immunofluorescence and immunoperoxidase staining were similar, immunoperoxidase showing a consistently better histological definition. We therefore concentrated on the results obtained by this method, which are summarised in tables 1 and 3. Positive staining was observed with all the monoclonal antibodies, although there was considerable variation in both intensity of staining and number of stained hepatocytes according to the monoclonal antibody used. The most intense staining was obtained with the anti-pre-S2 5535 and with the polyclonal anti-HBsAg. The anti-pre-Sl MA 18/7 also stained most sections (only two negative samples), but the intensity of staining was weaker. The second anti-pre-S2 antibody (Q 19/10), was positive on eight and negative on seven specimens. The lowest degree of positivity was obtained with the second antipre-SI antibody TO 606, which stained only one of the 15 samples. 
, confirming and expanding the findings of a previous study.' 7 It also shows that identification of pre-S antigen in paraffin wax sections largely depends on the reagents used.
Successful detection of pre-S polypeptides in paraffin wax embedded material has been previously reported using two of the monoclonal antibodies used in the present study, with similar results.'7 Thus, while we detected pre-SI in all but two biopsy specimens using MA 18/7, and pre-S2 in eight of our 15 specimens-weakly in five using Q 19/10, Dienes et al, using the same reagents, found pre-SI in 75% of their cases and weak pre-S2 in a smaller, unspecified, proportion of specimens.'7 When, however, we used TO 606 and 5535, which recognise different epitopes on pre-SI and pre-S2, we found that pre-S2 was present in all the specimens and pre-Si in only one of the 15 samples. Thus the intensity of staining and the number of positive cells clearly depend on the reagents used because antibodies of similar broad specificity give very different results, at least when used on paraffin wax embedded material. This difference may be explained by different affinities of the monoclonal antibodies used or by the fact that epitopes on intrahepatocytic pre-S antigens vary in their accessibility to antibodies or in their vulnerability to paraffin wax embedding. That pre-S epitopes behave differently when exposed to histological manoeuvres is illustrated by the finding that mild enzymatic digestion induced an appreciable decrease in the detectability of three of four determinants targeted by our panel of monoclonal antibodies.
The relation between the expression of pre-S polypeptides and HBV replicative activity has been investigated in previous studies with conflicting results. Theilman et al suggested that the presence of pre-SI in the serum and liver is indicative of an intense HBV replication,'8 while, according to Budkowska et al,'9 it is serum pre-S2 that correlates with viral replication. In our study the expression of pre-S1 and pre-S2 in the liver did not correlate with viral replication, because both polypeptides could be detected, irrespective of whether the patients had e antigen or e antibody in their sera, or core antigen in their livers. This lack of correlation agrees with the findings of Fraiese et al20 and Hadziyannis et al,21 who were also unable to associate the tissue expression of pre-S polypeptides with HBV replicative activity.
Budkowska et al suggested that pre-S2 polypeptides could be a marker of disease activity because their presence in the liver was found in the most severe of the HBV-related liver disorders. '9 In our series where diagnoses ranged from "healthy" carrier to chronic active hepatitis, we observed no correlation between the presence of pre-S1 and pre-S2 polypeptides and the degree of liver damage. As described for the surface antigen, however, an extensive positivity for either polypeptide tended to be a trait of the less severe conditions such as chronic persistent hepatitis and "healthy" chronic carriers. Larger studies are needed to substantiate this association and to clarify what role pre-S polypeptides have in the pathogenesis of HBV-related liver diseases.
In conclusion, the finding that pre-S1 and pre-S2 can be detected readily in paraffin wax embedded tissue opens the prospect for their characterisation, in stored material. The observation that reagents of similar broad specificities produced widely different results advocates the use of a panel of monoclonal antibodies in the study of pre-S polypeptides, at least on paraffin wax embedded material. 
